Silica microbead bioreactors (0.5 µm diameter) coated with DNA and enzymes were fabricated to measure reactive metabolite and DNA-adduct formation rates relevant to genotoxicity screening. Cytochrome (cyt) P450 2E1, cyt P450 cam , and myoglobin (Mb) were incorporated into thin films with DNA using the electrostatic layer-bylayer (LbL) method. The utility of these biocolloids was demonstrated by oxidation of guaiacol, styrene, and (4-methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK). Enzyme turnover rates for formation of reactive metabolites were monitored using gas chromatography/mass spectrometry (GC/MS) and liquid chromatography-mass spectrometry (LC-MS). Capillary LC-MS/MS was employed to determine DNA nucleobase adducts after catalyzing the reactive metabolite formation with DNAenzyme biocolloids and then using neutral thermal hydrolysis on the biocolloids. Dramatic improvements in surface area to volume ratio over similar films on macroscopic surfaces opens new avenues for genotoxicity screening and enabled the first use of pure cyt P450 enzymes in enzyme-DNA films to produce DNA adducts. The method makes possible identification and formation rate measurements of major and minor DNA adducts as well as the metabolites themselves in <5 min of reaction time using relevant human liver enzymes.Toxicity is often not identified sufficiently early in developing new pharmaceutical, agricultural, personal care, and dietary products. Roughly 30% of drug development failures result from toxicity issues, driving drug costs up significantly. 1-4 Conventional in vitro biological tests such as Ames, chromosome aberration, mouse lymphoma, and Comet assays provide qualitative answers to toxicity questions based on bulk DNA damage but do not give chemical structure or site-specific DNA damage information. 5,6 Animal testing may not relate to human exposure because of metabolic and physiological differences between humans and animal models. 2,4,7 While all these toxicity tests are valuable, we believe that rapid, high-throughput toxicity screening methods for new chemicals that provide chemical structure information about reactive intermediates at early stages of commercial development are important goals to complement conventional microbiological and animal tests.Bioactivation of xenobiotic molecules by metabolic enzymes often results in reactive metabolites that damage biomolecules, including DNA, in a major toxicity pathway. [8][9][10] An example is the metabolism of lipophilic compounds by liver cytochrome (cyt) P450 (or CYP) enzymes creating reactive electrophilic metabolites. 4,11 These electrophiles attack nucleophilic DNA sites, primarily guanines, potentially resulting in genotoxicity. Depending on the adduct site, additional metabolism, and DNA repair processes, covalent DNA adducts can lead to mutations, teratogenesis, and carcinogenesis. 12-14 Thus, nucleobase adducts are key biomarkers for predicting cancer risk in humans and for exposure to toxic chemicals, and sensitive liquid chromatography-mass spectromet...